Drug reference
nirmatrelvir-ritonavir
Antiviral combination (COVID-19 treatment). Protease inhibitor (nirmatrelvir); pharmacokinetic enhancer (ritonavir). No ATC code given in source, so omit.
Antiviral combination (COVID-19 treatment). Protease inhibitor (nirmatrelvir); pharmacokinetic enhancer (ritonavir). No ATC code given in source, so omit.
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Related guidelines
Other Unclassified drugs
Ask House about nirmatrelvir-ritonavir
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10